Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/IT Services/KPIT Technologies Share Price Analysis April 2026
IT ServicesTechnology

KPIT Technologies Share Price Analysis April 2026

By Zumedha Research Team on April 27, 2026 8 Min Read
KPIT Technologies — Zumedha Equity Research
Zumedha Equity Research
Research . Analysis . Insights
Current Market Price
₹735.00
as on 24 Apr 2025
ACCUMULATE
KPIT Technologies Ltd.
Pure-play Automotive ER&D | Software-Defined Vehicles | Embedded Software & AI | NSE: KPITTECH
ACCUMULATE Automotive ER&D Report Date: 24 April 2026
NSE KPITTECH
BSE 542651
ISIN INE04I401011
Face Value ₹10
52W High / Low ₹1,434 / ₹625
Mkt Cap ~₹19,900 Cr
Shares Outst. ~271 Cr
Index Nifty Midcap 100
Promoter Hold. 39.4%
§ 01 — Business Overview
India’s Only Pure-Play Automotive ER&D Company

KPIT Technologies is a global, independent software development and integration partner for the automotive and mobility ecosystem — the only listed Indian company with 100% revenue exposure to automotive engineering R&D. Founded in 1990 and headquartered in Pune, KPIT has ~13,000 “automobelievers” across engineering centres in Europe, USA, Japan, China, Thailand and India.

The company operates at the intersection of three megatrends: electrification (EV powertrain software, BMS, FCEV), autonomy (ADAS, autonomous driving perception and planning), and connectivity (vehicle OS, E/E architecture, over-the-air). KPIT’s service portfolio spans embedded software, AI-based perception, digital solutions, cybersecurity, and integrated validation — spanning passenger cars, commercial vehicles, off-highway, and micro-mobility.

Key product platforms include AutonomAI (AI-powered autonomous analytics), CyberHound (automotive cybersecurity), and AutonomX (connected vehicle platform). The company works directly with Tier-1 and Tier-2 OEMs across Europe, Japan, USA, and increasingly China and India.

FY25 Revenue
₹5,842 Cr
USD 691M | +19.9% YoY
FY25 PAT
₹719 Cr
+41.2% YoY
EBITDA Margin
21.0%
FY25 — met upgraded guidance
Operating CF
₹714 Cr
FY25 | Zero net debt
Q3 FY26 Revenue
₹1,617 Cr
+9.5% YoY | flat QoQ
Q3 FY26 PAT
₹133 Cr
–28.7% YoY | under pressure
TTM P/E
~26x
Suppressed by PAT trough
Net Debt
Zero
Net cash positive
§ 02 — Historical Financials
Strong FY25, Deteriorating FY26

KPIT delivered 19 consecutive quarters of revenue and operating profit growth through FY25. FY26 has been characterised by a sharp OEM ER&D spend reduction of 20–25% in passenger cars globally, which has compressed organic growth to near-zero and driven a sequential collapse in PAT from ₹244 Cr (Q4 FY25) to ₹133 Cr (Q3 FY26).

Metric (₹ Cr)FY23FY24FY25FY26EFY27E
Revenue3,3674,8725,8426,4007,400
YoY Growth55%44.8%19.9%~9.5%~15.6%
EBITDA6619851,2251,3441,620
EBITDA Margin19.6%20.2%21.0%~21.0%~21.9%
PAT365510719~689~870
EPS (₹)13.518.826.5~25.4~32.1
Operating CF204512714~620~780
RoE (%)28%32%35%~28%~32%
Net Debt00000
§ 03 — DCF Valuation
Intrinsic Value: ₹565 Base | ₹780 Bull

A 10-year discounted free cash flow model is used, anchored on a recovery in OEM ER&D spend from FY27, tapering to terminal growth. At 12% WACC and 5% terminal growth, the base-case DCF yields an intrinsic value of ~₹565/share, with a bull case of ~₹780 on faster SDV adoption.

10-Year Free Cash Flow Model — Consolidated
Bear Case Intrinsic Value
₹420
Base Case Intrinsic Value
₹565
Bull Case Intrinsic Value
₹780
WACC 12.0%
Terminal Growth 5.0%
FY26E FCF ₹580 Cr
FY27E Revenue Growth 15–17%
FY32–36 Growth 8.0%
Terminal Value PV ₹8,975 Cr
Net Cash Added ₹1,200 Cr
Shares Outstanding ~271 Cr
YearRevenue Est. (Cr)FCF Est. (Cr)FCF MarginPV @ 12%
FY27E7,40074010.0%661
FY28E8,60092010.7%734
FY29E9,7001,05010.8%747
FY30E10,8001,17010.8%743
FY31E11,9001,28510.8%729
FY32–36ETapering~6,200Avg 10.5%3,520
Terminal Value———8,975
Equity Value / Share———~₹565
§ 04 — Buy Range
Entry Strategy — Three Zones

Given that the stock has corrected ~49% from its 52-week high of ₹1,434, risk-reward is substantially improved. However, with Q4 FY26 results due in May 2026 and FY27 guidance as the pivotal catalyst, a tranche-based accumulation is recommended. Do not deploy the full position at current levels.

Strong Buy
₹580 – ₹640
Near DCF base case and 52W low support. Aggressive accumulation; deploy 50–60% of intended position. Maximum margin of safety.
Accumulate
₹640 – ₹760
Current trading zone. Deploy 30–40% in tranches. Hold remaining dry powder for post–Q4 results. Favourable risk-reward at this level.
Fair Value
₹760 – ₹900
Approaching FY27 earnings recovery price. Buy only on dips within this range. Do not chase above ₹900 until FY27 results confirm recovery.
§ 05 — Buy Scenario Analysis
Bull / Base / Bear — 18-Month Horizon

Three scenarios are modelled for a holding horizon of 12–18 months from current price of ₹735, covering key variables: OEM ER&D recovery pace, KPIT’s margin trajectory, and SDV deal pipeline momentum.

BEAR CASE
OEM ER&DStays depressed
FY27 Revenue₹6,800 Cr
FY27 EPS₹22–24
P/E Multiple22–24x
Probability20%
₹500–560
BASE CASE
OEM ER&DGradual recovery
FY27 Revenue₹7,400 Cr
FY27 EPS₹30–32
P/E Multiple28–32x
Probability55%
₹860–1,020
BULL CASE
OEM ER&DSharp rebound
FY27 Revenue₹8,200 Cr
FY27 EPS₹36–40
P/E Multiple33–38x
Probability25%
₹1,180–1,520
§ 06 — Sell Range
When to Exit — Three Trigger Zones

As a high-PE growth stock in a niche sector, KPIT can overshoot on both sides. Investors who build positions at current levels should define exit discipline in advance. Below are the three sell zones based on valuation excess and structural inflection signals.

Reduce
₹1,100–1,250
Approaching 35x FY27E earnings. Book 25–30% of position. Retain core holding if FY27 growth guidance remains strong.
Exit Trigger
₹1,300–1,450
At or near 52W high. Full exit for swing traders. Long-term holders retain if SDV pipeline visibility extends to FY28–29.
Avoid / Overvalued
₹1,500+
Exceeds 40x FY27E — peak-cycle valuation. Do not add fresh capital. Disciplined exit of all positions above this level.
§ 07 — Sell Scenario Analysis
Structural Exit Triggers
Overvalued Scenario
Stock re-rates to 38–42x on FY27 EPS recovery. Valuation disconnects from earnings growth. Gradual profit-booking warranted.
₹1,100–1,300
Exit Trigger Scenario
OEM EV capex cuts deepen permanently. EV/SDV transition delayed beyond FY28. Revenue growth stalls below 10% for two consecutive years.
Exit regardless of price
Structural Break
Major OEM (Europe/Japan) insources ER&D capability. KPIT loses wallet share (not just industry headwinds). M&A overpayment destroys FCF. Full exit mandatory.
Immediate Exit
§ 08 — Future Growth & Earnings Outlook
Structural Tailwinds, Near-Term Trough

KPIT’s long-term growth thesis is anchored to the single largest technology transformation in automotive history — the shift from mechanical to software-defined vehicles. Every car will run tens of millions of lines of embedded code by the early 2030s. KPIT is positioned as the specialist partner to OEMs who cannot build this capability in-house at sufficient speed or scale.

Software-Defined Vehicles (SDV)
The primary multi-decade tailwind. OEMs are transitioning from hardware-centric to software-centric architectures. KPIT’s core competency in vehicle OS, E/E architecture and AUTOSAR positions it as an irreplaceable Tier-1 software partner.
EV Powertrain & BMS Software
Battery management, FCEV solutions, and vehicle control units are high-value, recurring software domains. As EVs proliferate, software content per vehicle increases — directly benefiting KPIT’s TAM.
Commercial Vehicles & Off-Highway
Emerging adjacency. KPIT is expanding beyond passenger cars into trucks, construction equipment and micro-mobility. Q3 FY26 growth was driven by off-highway and commercial vehicle segments — validating this diversification.
India & China Automotive Markets
Both are early-stage for software content per vehicle. KPIT has established engineering centres in China and India. As domestic OEMs accelerate technology adoption, these geographies represent greenfield revenue.
AI-Led Solutions
KPIT’s AutonomAI platform and automotive-specific AI solutions (fine-tuned on OEM data) are gaining traction. Management has explicitly pivoted towards a solutions-based model which carries higher margins than pure-play services.
FY27 Recovery Catalyst
Management guided that FY27 growth will exceed FY26, and Q4 FY26 will be the highest growth quarter of FY26. New vehicle programmes, deal wins of $202M in Q3, and China/India expansion support recovery confidence.
ProjectionFY26EFY27EFY28EFY29E
Revenue (₹ Cr)6,4007,4008,6009,700
Revenue Growth~9.5%~15.6%~16.2%~12.8%
EBITDA Margin21.0%21.9%22.5%23.0%
PAT (₹ Cr)~689~870~1,075~1,260
EPS (₹)~25.4~32.1~39.7~46.5
§ 09 — Risks & Catalysts
What Can Move This Stock
Bull Catalysts
OEM ER&D spend recovers faster than expected in H1 FY27 — sharp earnings upgrades follow
Strong FY27 guidance issued at Q4 FY26 results (May 2026) — re-rating trigger
India/China automotive software market ramps ahead of schedule
AI-led AutonomAI platform lands major OEM deal — solutions revenue de-risks services mix
Commercial vehicle / off-highway adjacency scales rapidly, broadening revenue base
Acquisitions (e.g. OXI SRL, Caresoft) integrate smoothly, add margin-accretive revenue
Bear Risks
EV/SDV transition delayed globally — OEMs cut capex further in CY2026–27
US and EU tariffs compress OEM investment budgets, extend ER&D freeze
PAT margin stays below 12% — ESOP dilution and acquisition costs persist
Major OEM insources ER&D capability — KPIT loses wallet share structurally
Japan and USA OEM discretionary cuts deepen; Europe recovery proves ephemeral
Kotak Institutional Sell thesis plays out — consensus EPS estimates too high for FY27
§ 10 — Peer Comparison
KPIT vs. Indian ER&D Peers

KPIT commands a premium valuation over generalist ER&D peers given its 100% automotive focus, superior margin profile, and pure-play positioning. Post-correction, it trades at a significant discount to historical multiples and is now approaching Tata Elxsi’s valuation — despite differentiated business models.

CompanyCMP (₹)Mkt Cap (Cr)TTM P/EEV/EBITDARevenue Growth (FY25)EBITDA MarginRating
KPIT Technologies₹73519,900~26x~18x+19.9%21.0%Accumulate
Tata Elxsi~₹5,20032,000~38x~27x+8%28.5%Reduce
Cyient DLM~₹4805,800~28x~16x+18%12.5%Accumulate
L&T Technology Services~₹4,20044,000~34x~24x+15%19.5%Accumulate
Mphasis~₹2,10039,000~28x~20x+6%18.2%Accumulate

KPIT’s TTM P/E of ~26x is the lowest in its history over the past 3 years, entirely driven by the cyclical PAT compression. On a normalized FY27E EPS basis, it trades at ~23x — well within the 28–35x band that quality ER&D companies deserve. Tata Elxsi, despite decelerating growth, still commands 38x, illustrating the re-rating potential once KPIT’s earnings recover.

§ 11 — Analyst Consensus
Street View — April 2026
JM Financial BUY ₹860
Goldman Sachs NEUTRAL ₹1,100
JPMorgan OVERWEIGHT ₹1,400
Kotak Institutional Equities SELL ~₹700
Zumedha Equity Research ACCUMULATE ₹860–1,020
ACCUMULATE
KPIT Technologies Ltd. — NSE: KPITTECH
CMP
₹735
DCF Base Value
₹565
12–18M Target
₹860–1,020
Strong Buy Below
₹640
KPIT Technologies is a high-quality franchise navigating a genuine cyclical trough — not a structural decline. The SDV thesis is intact; the OEM ER&D freeze is an industry-wide phenomenon, not a KPIT-specific execution failure. At ₹735, the stock has corrected ~49% from its 52-week high, compressing the TTM P/E to ~26x — its lowest in three years. Our DCF base case of ₹565 reflects a conservative recovery; the current price already embeds meaningful pessimism. On FY27E EPS of ₹30–32, the stock trades at ~23x — compelling for a niche, zero-debt ER&D leader with 20%+ EBITDA margins and double-digit FCF margins. The Q4 FY26 results (May 2026) and FY27 guidance are the next critical inflection. A strong quarter plus credible guidance could re-rate the stock 20–30% in a single session. We recommend deploying 40% of the intended position in the ₹720–750 zone and holding 60% dry powder for post-results accumulation in the ₹640–700 band if weakness persists.
Zone 1 — Strong Buy
₹580 – ₹640
Near 52W low. Aggressive accumulation. Maximum margin of safety.
Zone 2 — Accumulate (Current)
₹640 – ₹760
Current zone. Tranche buying. Hold dry powder for post-Q4 reaction.
Zone 3 — Fair Value Boundary
₹760 – ₹900
Buy only on dips. Do not chase above ₹900 ahead of earnings confirmation.
Disclaimer: This report has been prepared by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. All financial data, estimates, and projections are based on publicly available information and Zumedha’s proprietary analysis. Past performance is not indicative of future results. Equity investments are subject to market risk and may result in the loss of principal. Readers should consult a SEBI-registered investment advisor before making any investment decision. Zumedha Equity Research and its analysts may or may not hold positions in the securities mentioned herein. This report is not intended for distribution in any jurisdiction where such distribution would be unlawful. © 2026 Zumedha Equity Research — zumedha.com. All rights reserved.
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Cyient Ltd DCF Valuation Share Price April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS